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http://www.clintransmed.com/content/2/1/12RESEARCH Open AccessA pilot study demonstrating a non-invasive
method for the measurement of protein turnover
in skin disorders: application to psoriasis
Claire L Emson1*†, Sarah Fitzmaurice2†, Glen Lindwall1, Kelvin W Li1, Marc K Hellerstein3, Howard I Maibach2,
Wilson Liao2 and Scott M Turner1Abstract
Background: Previous studies of epidermal kinetics in psoriasis have relied on invasive biopsy procedures or the
use of radioactive labels. We previously developed a non-invasive method for measuring keratin synthesis in human
skin using deuterated water labeling, serial collection of tape strips and measurement of deuterium enrichment in
protein by mass spectrometry. This powerful method can be applied to measure other skin proteins and lipids
collected by tape stripping. Here, for the first time, we apply this technique to investigate the epidermal kinetics of
psoriasis, the first step in defining a kinetic profile for normal skin versus activated or quiescent psoriatic skin.
Methods: Psoriatic subjects were given 2H2O orally as twice-daily doses for 16–38 days. Affected and unaffected
skin was sampled by tape stripping and washing (modified Pachtman method). Proteins were isolated from the
tape strips by a method that enriches for keratin. Turnover times were determined by gas chromatography/mass
spectrometry. Kinetic data were compared to transepidermal water loss (TEWL).
Results: Deuterium-labeled protein from lesional psoriatic skin appeared at the skin surface within 3–8 days of label
administration, whereas labeled protein from non-lesional skin requires 10–20 days to appear. Psoriatic skin had
similar rate of growth despite varying anatomic location. Proteins recovered from tape strips were identified by
nanoscale liquid chromatography/tandem mass spectrometry. Isolated peptides were >98% from keratin in
uninvolved skin and >72% keratin in psoriatic skin. Revealing that one-quarter of all newly synthesized proteins in
psoriatic skin are antimicrobial defense and other immune-related proteins. TEWL values were greater in lesional
than non-lesional skin, suggesting barrier compromise in psoriatic skin despite increased clinical thickness.
Conclusions: This simple, elegant, and non-invasive method for measuring epidermal protein synthesis, which can
also be adapted to measure epidermal lipids, provides a metric that may reveal new insights into the mechanisms
and dynamic processes underlying psoriasis and may also provide an objective scale for determining response to
therapeutic agents in pre-clinical and clinical trials. This opens a pathway to the non-invasive study of kinetics of
protein formation in psoriasis or other skin diseases.
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Due to the hyper-proliferation and hyper-keratinization
observed in psoriatic skin, there has been substantial
work examining epidermal keratinocyte and keratin dy-
namics. Abnormal epidermal turnover can impair skin
barrier function and tissue repair; hence keratinocyte or
keratin turnover may be critical in disorders of the skin
as well as in response to therapy [1].
Dislipidemia is a further co-morbidity in this systemic
disease. Skin lipid content is particularly critical for
maintaining skin barrier function and regulating water
loss. The stratum cornea is enriched with organized
layers of intercellular lipids composed primarily of
ceramides, cholesterol and fatty acids [2]. Psoriatic skin
displays abnormal expression and abnormal location/dis-
tribution of lipids, and this appears to be at least partly
related to disease severity. Therefore there may be sig-
nificant changes in lipid kinetics in psoriatic individuals
reflecting this defect in lipid homeostasis.
We have previously developed methods to measure
the kinetics of keratin [3,4], triglycerides, fatty acids and
cholesterol [5] using heavy water in human tissue and
have also measured kinetics of complex lipids (e.g.
galactocerebrosides) from brain myelin [6].
Protein synthesis can be conveniently measured by use
of a continuous label administration, rise-to-plateau ap-
proach, based on the incorporation of deuterium (2H)
from heavy water (2H2O) into nonessential amino acids
(NEAA) in newly synthesized proteins [6]. This 2H2O
technique has been used to measure the synthesis of
proteins in muscle, bone, liver, lung and other tissues
[6-10]. Similarly incorporation of 2H from 2H2O into
cholesterol ester, free fatty acids or triglycerides can be
used to determine the synthetic rates of lipid turnover.
When adhesive tape strips are applied to the skin sur-
face in humans, a layer is removed composed primarily
of lipids, keratin, and other epidermal constituents. The
turnover rate of epidermal keratin from tape strips pro-
vides an accessible strategy for assessing psoriatic disease
activity and treatment effectiveness. We have previously
measured epidermal keratin synthesis by combining col-
lection of tape strips with heavy water labeling and mass
spectrometric analysis [4]. We observed that keratin and
keratinocytes have equivalent rates of fractional synthesis
in a psoriatic animal model and that keratin turnover
from tape strips matches keratin turnover from tissue
samples [4]. Here, we have applied our keratin synthesis
method to measure skin protein turnover rates in in-
volved and uninvolved skin of psoriatic individuals.
Methods
Study population
Four males (aged 49–67 years, mean 51.2 yrs, SD. 9.8)
participated. All had dermatologist-confirmed severeplaque psoriasis. All subjects had no family history of
disease and were concurrently receiving Goeckerman
treatment at the University of California San Francisco
(UCSF) Psoriasis and Skin Treatment Center. Goec-
kerman treatment involves exposing affected skin areas
to ultraviolet B phototherapy and crude coal tar applica-
tion daily, Monday through Friday. Subjects had been on
a variety of prior therapies including UVB or UVA
phototherapy, methotrexate, psoralen, cyclosporine, eta-
nercept, adalimumab, efalizumab, infliximab, and ale-
facept but all were considered recalcitrant to treatment.
None of the subjects had systemic treatment for psoria-
sis for at least one month or phototherapy for at least
2 weeks prior to study onset. Subjects were instructed to
use nothing but emollients or moisturizers at the areas
being sampled. Two plaques and two unaffected areas
were sampled from each subject. Sampled areas were
blocked from receiving Goeckerman treatment by daily
application of Telfa pads (Covidien, Mansfield, MA) se-
cured with micropore tape (3 M, St. Paul, MN). The
study was approved by the Committee on Human Re-
search at UCSF. All participants gave written informed
consent. Declaration of Helsinki protocols were
followed.
Heavy water (2H2O)
Subjects drank 50 ml of 70% deuterated water (2H2O)
twice daily Monday through Friday for 16 to 38 days. Sal-
iva samples were collected on the day of tape stripping as
previously described [4]. Salivettes were stored at −20°C
until analysis by mass spectroscopy.
Transepidermal water loss measurements and skin
washing procedure
Transepidermal water loss (TEWL) was measured using
an evaporimeter (Delfin VapoMeter™, Delfin Technolo-
gies Ltd., Finland). The probe was held perpendicular to
the skin surface until a stable TEWL value was esta-
blished (10–20 seconds). Two measurements were done
at each of the 4 sites sampled. Skin washing was by a
modified Pachtman method [11] in which a plastic cylin-
der 2.4 cm in diameter was pressed against the skin.
One milliliter of wash solution (0.1% Triton X-100) was
placed in the cylinder, and the skin surface was rubbed
briskly with a Teflon policeman for 5 seconds. The solu-
tion containing scrubbed skin cells was collected with a
sterile pipette, placed in Eppendorf tubes, and stored at
4°C until analysis. Details on measuring TEWL are sum-
marized in [12].
Tape stripping procedure
For each of two affected and two unaffected sampling
sites, standard adhesive disks (D-Squame, CuDerm.
Dallas Texas) with a 2.2 cm diameter were placed on the
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then were removed from the skin using forceps. Twenty
sequential D-Squame disks were taken from one area in
each site. Tape strips were collected every 2–5 days, each
time moving the collection area within each site. Sam-
pling times were chosen to coincide with Goeckerman
clinic visits and around subject availability to maximize
compliance. Disks were measured by infrared densitom-
etry [13], then were pasted onto laminated collection
cards. Collection cards were stored at −20°C until ana-
lysis. A single physician conducted all tape strip collec-
tions. Additional methodological details are found in
[14].
Stratum corneum infrared densitometry
Twenty sequential tape strippings were placed adhesive
side up on standard collection strip for a broad slit infra-
red densitometer (Squame Scan™ 850A Heiland elec-
tronic, Wetzlar, Germany). Stratum corneum per tape
strip is indirectly determined by optical absorbance [15].
Keratin preparation
Skin keratins were isolated from tape strips as previously
described [4]. Briefly, a piece cut from each tape strip
was placed in a microcentrifuge tube and washed in a
high salt/mild detergent buffer to extract non-keratin
proteins. The wash was discarded and keratins were sol-
ubilized in 1% SDS in water by heating at 100°C. Tape
strips were removed from the tubes and the SDS-keratin
complex was precipitated by adding KCl to the solution.
Pellets were resuspended in 6 N HCl for hydrolysis to
amino acids preparatory to derivitization and GC/MS
analysis.
Pre-stripping skin washings were centrifuged 15 min
at 18,000 x g in microcentrifuge tubes and separated
into supernatant and pellet. The resulting pellets were
processed as for tape strips, starting with the high salt/
detergent washing. The supernatants were taken to 20%
trichloroacetic acid, incubated overnight at 4°C, and
centrifuged 15 min at 18,000 x g to precipitate any sol-
uble proteins. These pellets were also processed as for
tape strips.
Peptide identification
Tape strip proteins were prepared for proteomic analysis
using a protocol from the Vincent J. Coates Proteomics
Laboratory at the University of California, detailed at
their web site [16].
Pellets of the SDS-keratin complex precipitated by KCl
as described above were mixed with Laemmli buffer
(BioRad) and loaded on a 4-20% tris HCl gel (BioRad
Criterion). The gel was run at 20 V until the dye front
was about 1 cm into the gel and the largest of the
prestained molecular weight markers (BioRad PrecisionPlus) were beginning to separate from the dye front. The
gel was removed from the cassette, washed extensively
in multiple changes of water and stained with Gelcode
BlueW Coomassie stain (Pierce/Thermo Fisher). After
additional extensive washing, gel lanes were broadly cut
to cover the range of the molecular weight markers. Cut
gel lanes were digested with trypsin and extracted per
the University of California protocol [17] and submitted
to that facility for analysis. Samples were run on a
Thermo LTQ XL linear ion-trap mass spectrometer with
LC-nanoelectrospray source. The program Sequest [18]
identified peptides and proteins from the complete hu-
man database.
Analysis of body 2H2O enrichments in body water
2H2O enrichment in saliva samples was measured as
previously described [17,19]. Analysis of the deuterium
content was performed by quadrupole GC/MS (Agilent
5973/6980) in negative chemical ionization mode (NCI-
GC/MS), with helium as carrier and methane as reagent
gas.
Calculation of fractional synthesis
In order to determine the fractional synthesis of keratin,
alanine from the acid hydrolysates was modified to
pentofluorobenzyl derivatives and by GC/MS as previ-
ously described [7]. Briefly, the proteins were hydrolyzed
by incubation in 6 N HCl for 16 hours, dried under vac-
uum and then suspended in a solution of 50% aceto-
nitrile and 50 mM K2HPO4 pH 11. Twenty microliters
of pentafluorobenzyl bromide were added before a 1 hour
incubation. Derivatives were extracted into ethyl acetate.
The derivatized alanine was analyzed by GC/MS, perfor-
med in the negative chemical ionization mode. Incorpor-
ation of 2H into protein-bound alanine was calculated as
the molar fraction of molecules with one excess mass
unit above the natural abundance fraction (EM1). Frac-
tional turn over (f ) was calculated as the ratio of the
EM1 value in protein-bound alanine at the maximal
value possible (representing 100% newly synthesized
protein [7]) at the time-averaged body 2H2O enrichment
present until the time the tape strip was obtained.
Results
Appearance of labeled protein in psoriatic lesions is rapid
and the detected proteins are nearly completely newly
synthesized material.
Deuterated proteins were detected in tape strips from
psoriatic lesions as early as 3 days after starting heavy
water administration (Figure 1). Label was observed in
all samples from lesions between 3–8 days after label ad-
ministration. Because the first time point sampled was
on day 3, initial appearance time may have been even
sooner. Moreover, the protein isolated was nearly 100%
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Figure 1 Skin keratin enrichments. Measured skin keratin enrichments for both psoriatic and uninvolved skin from four individuals (a-d), based
on deuterium incorporation in alanine, are plotted together with measured body water enrichments. Some individuals were assessed at two
anatomical locations (e-f). Deuterium incorporation at the surface of psoriatic skin lags body water levels by only a few days, whereas the lag is
much longer in uninvolved skin. Body water enrichment has been demonstrated to be related to alanine enrichment by a factor of 2.7 and has
been plotted here using that correlation.
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corneum compartment in psoriatic subjects is replaced
in less than 5 days.
Protein turnover in uninvolved skin is slower than that of
involved psoriatic lesions.
Skin tape strips collected from the same individuals but
from uninvolved skin had significantly delayed appearanceand slower turnover rates (Figure 1). Appearance of label
was detected beginning around 10–20 days after the start
of labeling. These results are consistent with our published
data of keratin turnover rates determined from healthy,
non-psoriatic individuals [4]. Although psoriasis is consid-
ered a systemic disease, these results indicate that the
kinetics of uninvolved skin in psoriasis patients were com-
parable to normal skin and did not exhibit an increased
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not correlate with subject age for involved or uninvolved
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We sampled two anatomical locations on each psoriatic
subject. Observations of protein turnover rates in in-
volved and uninvolved skin were similar between the
two different sites (Figure 1). Rates were similar within
subjects and were location independent. In addition to
this intra-subject similarity, inter-subject turnover rates
were also remarkably consistent. Protein from tape strips
and protein pelleted from skin washings (Pachtman
technique) gave the same values for label incorporation
(Figure 2). Washings from psoriatic lesions contained
abundant protein but there was not always enough ma-
terial in washings of uninvolved skin to be evaluated this
way.W
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Figure 2 Protein identification of soluble and insoluble skin
proteins. Prior to tape stripping, the skin surface was gently
washed. The washes from psoriatic lesions contained abundant
protein. Turnover rates of wash derived proteins were compared to
tape strip proteins. The wash liquid was collected, centrifuged to
separate soluble and insoluble fractions (tape strip processing
removes soluble proteins), and processed using the same washing/
SDS extraction process used for tape strips. a). Incorporation of
deuterium from ingested heavy water in tape strips and in proteins
from the wash. b). SDS PAGE stained with coomassie blue
comparing the proteins recovered from a tape strip (middle lane)
with the soluble and insoluble fractions from the skin surface wash
of the same subject.The kinetically assessed tape strip proteins collected were
predominantly keratin
This method was originally designed to enrich for and
focus on keratins, washing away the readily soluble pro-
teins before extracting the less-soluble keratins. Proteins
from the involved psoriatic skin had a more complex
banding pattern by SDS PAGE (data not shown). The
samples recovered from tape strips from the uninvolved
and psoriatic skin of subject 1 were therefore analyzed
for protein content by nanoscale liquid chromatography-
tandem mass spectrometry (LC/MS/MS). Table 1 lists
the proteins observed in the uninvolved skin and the
most prominent of the proteins from the psoriatic skin.
98% of the peptides identified from the uninvolved tape
strips were derived from keratin, as determined by LC/
MS/MS spectral counts, consistent with our previous
findings [4]. Of the identified peptides from involved
skin tape strips, 72% were keratins. The different
makeup of the surface proteins in the involved skin
reflected the disrupted profile of the plaque with detec-
tion of inflammatory and antimicrobial defense proteins
(S100A8, Histone H4, and SERPINB4) as well as epithe-
lial organizational proteins (Plakoglobin). A technical
point worth noting regarding kinetics, however, is the
near 100% fractional replacement of protein observed in
epidermal skin strips from psoriatic subjects (Figure 1).
This finding means that the keratin that is present is
fully and rapidly turned over, regardless of the presence
of contaminant proteins. Thus, the altered kinetics of
label appearance in proteins from psoriatic patients does
not represent labeling of inflammatory proteins but must
primarily reflect turnover of keratin itself.TEWL data demonstrated decreased barrier integrity of
involved psoriatic skin
Transepidermal water loss (TEWL), a measure of epider-
mal water barrier function, was increased in the involved
skin, demonstrating that the active psoriatic process is
associated with decreased barrier function (Figure 3). An
optical densitometry measure of tape protein levels was
performed but yielded unreliable results due to the un-
even adherence of psoriatic scale to the tape strips (data
not shown).
Table 1 Proteins observed by mass spectrometry from uninvolved and psoriatic skin of a single patient
Uninvolved skin # of unique
peptides
total peptide
count
mol wt
(Da)
peptide count/mol
wt x 103
Keratin 10 34 91 58827 1.55
Keratin 1 37 95 66039 1.44
Keratin 2 34 66 65433 1.01
Keratin 6A 10 24 60045 0.40
Keratin 77 (Keratin 1B) 16 24 61801 0.39
Keratin 5 11 20 62378 0.32
Keratin 14 5 7 51622 0.14
Glycine-N-acyltransferase isoform b 2 2 18506 0.11
Keratin 6 irs4 3 6 57865 0.10
Glyceraldehyde-3-phosphate dehydrogenase 2 3 36053 0.08
Keratin 9 4 5 62064 0.08
Keratin 5b 3 4 56866 0.07
Transglutaminase 3 precursor 2 2 76731 0.03
Psoriatic skin # of unique
peptides
total peptide
count
mol wt
(Da)
peptide count/mol
wt x 103
Keratin 6A 58 191 60045 3.18
Keratin 10 46 147 58827 2.50
Keratin 1 50 128 66039 1.94
Keratin 14 36 92 51622 1.78
Keratin 2 34 81 65433 1.24
Keratin 5 29 58 62378 0.93
Keratin 17 19 44 48106 0.91
Keratin 16 22 46 51268 0.90
Histone cluster 4 4 8 11367 0.70
S100 calcium-binding protein A8 3 7 10834 0.65
Serine (or cysteine) proteinase inhibitor, clade B, member 4 6 14 44854 0.31
Pyruvate kinase, muscle isoform 2 9 18 58062 0.31
Junction plakoglobin 12 22 81745 0.27
Proteins observed by peptide mass spectrometry from uninvolved and psoriatic skin of a single patient. For each protein the number of unique peptides and the
total peptide count, which includes multiple observations of the same peptide, are listed. The peptide count has been divided by the molecular weight and
proteins are listed in order of the resulting product. All 13 proteins identified from the uninvolved skin of this individual are listed together with the first 13 (of 66
total) proteins seen in psoriatic skin.
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There have been previous attempts to measure cell kinet-
ics in both normal and psoriatic skin. Methods that have
been used to measure the proliferative activity of the skin
include bromodeoxyuridine (BrdU), DNA flow cytometry
(FCM), cell cycle markers such as Ki-67 antigen and
radio-isotopic tracers. Increased DNA synthesizing cells
have been demonstrated in the psoriatic epidermis using
methods, including tritiated thymidine and Ki-67 staining.
In-vivo tritium labeling studies by Weinstein from the
1980’s predicted a cell cycle time of 311 hr in normal epi-
dermis, 8 fold longer than the 36 hr cell cycle period in
psoriatic epidermis [20].
Using the technique applied in the present study, our pre-
vious clinical studies measuring keratin synthesis in normal
subjects demonstrated a transit time of about 18 days fromthe start of heavy water administration until label appear-
ance at the skin surface [4]. A degree of variability in keratin
synthesis kinetics was also observed among normal sub-
jects. Here, we demonstrated similar appearance times for
uninvolved skin from psoriatic individuals. This implies that
basal turnover rates in skin are similar in psoriatic and non-
psoriatic individuals, and that abnormal keratin kinetics are
only observed in skin undergoing active disease. We also
observed similar keratin turnover rates in uninvolved skin
in different anatomic locations on the same individual,
again suggesting consistent basal skin kinetics for these sub-
jects except in areas of psoriatic plaques.
Most strikingly, labeled protein (predominantly keratin)
was detected in lesional psoriatic skin within as little as
three days following heavy water administration. Further-
more, as well as the rapid appearance time of labeled
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Figure 3 Transepidermal water loss from psoriatic subjects. Trans-epidermal water loss (TEWL) for both psoriatic and uninvolved skin from
four individuals (a-d) was measured by contacting an evaporimeter to the skin surface. Some individuals were assessed at two anatomical
locations (e-f). TEWL measurements comparing psoriatic skin and non-lesional control skin is shown as a function of time. Each data point is an
average of 2 values with standard deviations as indicated.
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appeared to be nearly 100% newly synthesized during the
labeling period. The calculated fractional synthesis rate
(Figure 1) reflects the rate of protein synthesis but does not
factor in the total protein present in the skin. Since keratin
expression is elevated in psoriatic individuals, our observed
increased fractional synthesis rate of keratin and rapid time
to appearance indicate that the absolute keratin synthesis
rate (mg new keratin per day) must be dramatically in-
creased in psoriatic skin during active disease. Despite the
small scale of this study, with limited subject number and
sampling times, the difference in keratin turnover between
involved and non-involved skin is striking and consistent.All subjects had similar disease severity being diagnosed
with severe plaque psoriasis (Table 2). Since subjects were
deliberately selected to have severe plaque psoriasis we did
not observe a correlation between synthesis rates and dis-
ease severity. Subject 3 had the most number of previous
treatments including multiple systemic treatments and
multiple biologic therapies. Despite his high severity, Sub-
ject 3 did not display the shortest or longest lag for involved
or uninvolved skin (8 and 15 days respectively). We did not
observe a correlation between demographics, disease sever-
ity or previous treatment with the keratin kinetics however
with such a small number of subjects this study is not
powered to reveal these differences.
Table 2 Subject demographics and clinical information
Subject 1 2 3 4
Age 49 49 41 67
Gender M M M M
BMI 25.7 32.5 32.1 31.4
Disease
severity
Severe plaque
psoriasis
Severe
plaque
psoriasis
Severe plaque
psoriasis
Severe
plaque
psoriasis
Family
history
No family
history of
psoriasis.
No family
history of
psoriasis.
No family
history of
psoriasis.
No family
history of
psoriasis.
Previous
therapy
UVB
phototherapy
and
methotrexate
UVB
phototherapy
UVB and
psoralen UVA
phototherapy,
methotrexate,
cyclosporine,
etanercept,
adalimumab,
efalizumab,
infliximab, and
alefacept
UVB and
psoralen UVA
phototherapy
Demographic and clinical data of the four subjects is shown.
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of disease activity. However the PASI score is not entirely
objective and may be subject to significant inaccuracy
(reviewed in [21]). Instead we utilized trans-epidermal
water loss as a quantitative measure of stratum corneum
dysfunction (Figure 3). This readout could distinguish be-
tween involved and uninvolved skin, highlighting the
compromised barrier function of psoriatic skin and cor-
roborating the kinetic data, but demonstrated a high de-
gree of noise in day to day readings across the time course
which would make it unsuitable for longitudinal assess-
ment of response to therapy in a clinical trial. We also
assessed subject disease activity using an optical readout.
“SquamScan” (data not shown) did not reveal any signifi-
cant difference between involved and uninvolved skin.
Whilst diagnosis and management of individuals by the
clinician is not hampered by the noise and insensitivity of
these metrics it highlights the need for quantitiative tools
for use in clinical trials to assess responses to novel ther-
apies. Future studies could apply the keratin synthesis bio-
marker to cross sectional studies to measure the kinetic
rates of variable disease severities or longitudinal studies
examining kinetics in response to treatment to develop
therapeutics and further the understanding of keratin dy-
namics in this disorder.
The non-invasive nature of the tape strip approach de-
scribed here is simple and easily applied in a clinical set-
ting. However, by collecting total skin proteins the
differential composition of skin proteins between involved
and non-involved skin must be considered. This method
measures the weighted average of all protein in the sample
and thus is biased to the most abundant. Accordingly, weperformed LC/MS/MS to identify the proteins that were
being kinetically characterized.
The proteins in Table 1 are ordered by dividing the pep-
tide count, the total number of times peptides from a
given protein are observed, by the molecular weight. This
yields a number which is crudely related to abundance in
the sample. Although there are some problems with using
this ordering method (such as variations in efficiency of
peptide ionization, variation in peptide resistance to prote-
olysis or poor peptide chromatograph) it has been demon-
strated that abundance changes between related samples
can be analyzed by this method [22].
Keratins 6A and 14 were greatly increased in apparent
abundance relative to keratins 1 and 10 in psoriatic skin as
compared to uninvolved skin. This data supports previous
understanding of psoriatic lesions; keratins 6A and 14 are
more prominently present in psoriatic than uninvolved tis-
sue and keratins 16 and 17 are notably expressed in psori-
atic tissue but are undetected in uninvolved skin [23].
Additional observations include that greater than 98%
of all peptides observed in the uninvolved skin were
from keratins. Thus, protein isolated from uninvolved
skin by this method is almost all keratin [4]. Isolates
from psoriatic skin are more complex; 66 proteins were
detected. Keratins comprised only about 73% of all pep-
tides observed in psoriatic skin, although the first 8 pro-
teins were all keratins. The non-keratin proteins which
appeared to be moderately abundant in this psoriatic
tissue were predominantly proteins associated with
epithelial organization (Plakoglobin), or epithelial innate
immune responses such as inflammation (SERPINB4,
S100A8) or antimicrobial (Histone H4). Many of these
proteins have been previously demonstrated to be ele-
vated in psoriatic lesions [24-27]. However, because es-
sentially 100% of protein observed in epidermal skin
strips from psoriatic subjects was newly synthesized
(Figure 1), the altered kinetics of label appearance in
proteins from psoriatic patients cannot simply represent
labeling of inflammatory proteins but primarily reflects
turnover of the predominant protein, keratin.
Another point worth noting is that our approach yields
an average turnover rate for the extracted proteins. This
approach works well for healthy epidermis which is
thought to be composed largely of layers which work their
way to the surface at a fairly uniform rate. Psoriatic skin is
less ordered and could conceivably vary in turnover rates
of some components. In the future, use of advanced dy-
namic proteomic techniques to pull out turnover rates of
individual proteins from the labeling of peptides may be
applied with the same heavy water labeling/skin strip col-
lection methodology that is described here.
The current technique has distinct advantages over the
traditional methods of determining cell proliferation that
have been described previously. Many kinetic studies
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sies with radioactive tracers. Both BrdU and 3HdT are toxic
and mutagenic, providing ethical and practical consider-
ations preventing their use. Stable isotopes such as deuter-
ium (2H) have a long history as safe, effective methods for
measuring synthesis of molecules in experimental animals
and humans. Because deuterium is safe for human use, it is
easily translated into clinical studies. By using stable iso-
topes one can label for longer periods allowing the disease
to be tracked over time, for example during a treatment or
intervention. Further, many historical studies use punch bi-
opsies; this is invasive and not suitable for already damaged
lesional skin, especially since injury alone may induce fur-
ther exacerbations in uninvolved skin (Koebner effect).
Tape stripping is a less invasive method of sampling the
skin surface and also allows us to take multiple samples
from the same subjects over time. No Koebner effect was
observed in any subject during this study. The safety and
simplicity of this tape-stripping technique enables the possi-
bility for much larger scale clinical studies, giving a more
accurate determination of kinetics based on a larger popula-
tion size.
Administration of deuterium oxide and collection of
skin samples is very easy making this assay highly at-
tractive; however as with any new assay feasibility and
cost must be considered. Unlike other methods of as-
sessing protein turnover which historically have used
short term i.v. infusion of radiolabelled tracer or invasive
punch sampling (discussed above) in this study subjects
drink pre-bottled D2O at home and are then tape stri-
pped. In our study tape strips were collected by a single
person to minimize any sampling variability between
subjects in such a small cohort and because the subjects
were already visiting the clinic for pre-existing visits.
However skin collection could also be carried out by the
subject in an outpatient setting as tape strip collection is
painless and requires minimal training. Following collec-
tion tape strips are stuck onto a laminated card and can
be stored in the subjects’ freezer until collection. It is
conceivable to imagine a kit mailed to the subjects home
of D2O, tape strips and collection cards. The abundance
of keratin in the tape strip sample means protein isola-
tion is relatively easy for any chemical laboratory.
We envision this method being most applicable to inter-
pretation of clinical trials rather than routine disease
management of patients. In this scenario access to a
mass spectrometry instrument and chemical lab is not
limiting. Additionally, new mass spec methods such
as MRM or SISCAPA, are high through put and have
been used to translate biomarker approaches from dis-
covery to clinical trials. These methods can be used to
measure a targeted protein of interest from a complex
biological sample and this method could be adapted to
this platform.The availability of a rapid, quantitative biomarker of
disease and treatment efficacy, either protein or lipid,
would have wide spread clinical applications. It would
enable the basic study of disease pathogenesis and allow
for the rapid assessment of novel therapeutics (decreas-
ing the time and cost of clinical trials and reducing pa-
tient exposure to new agents with unknown side effects).
We predict that our keratin synthesis biomarker would
be especially suitable to detecting early response to treat-
ment prior to detection by traditional clinical metrics.
An objective marker of psoriatic disease activity, such as
the keratin kinetic biomarker described here, could also
be used to assess the severity of other psoriasis sub-
types such as palmoplantar psoriasis, guttate psoriasis,
inverse psoriasis, and erythrodermic psoriasis. These
subtypes are not well measured by the current scales
which were designed to evaluate plaque psoriasis. The
method described here is potentially applicable to all
phenotypes of psoriasis.
As well as analyzing keratin turnover as described above,
we can obtain other skin constituents from the tape strip.
We have previously developed methods to measure the
kinetics of lipids [5,6] and cell proliferation [28,29] using
heavy water in human tissue. The adaption of this tape
strip technique to enable kinetic assessment of specific
skin cells, lipids or proteins may yield further insights into
the mechanisms behind this complex disorder. We have
recently devised methods of measuring multiple protein
kinetics simultaneously [30-32] which could further ex-
pand the utility of this method in looking at the pathology
of psoriasis or response to treatment.Conclusion
In summary, we have demonstrated that keratin turnover
is dramatically accelerated in psoriatic lesions while unin-
volved psoriatic skin has keratin turnover rates similar to
non-psoriatic individuals. Although only a pilot study this
suggests that keratin synthesis kinetics may be a sensitive
biomarker of psoriasis which could be used to assess indi-
vidual disease activity or to provide a quantitative measure
of response to treatment in clinical trials. This kinetic
method of assessing skin activity or skin turnover is non-
invasive and safe. Application of this technology could be
used as a quantitative means to standardize either basic
science or clinical studies of psoriasis, or of other skin
conditions such as icthyosis or aging skin.Abbreviations
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